Canada markets closed

Aion Therapeutic Inc. (ANTCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0060-0.0060 (-50.00%)
At close: 02:29PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.00M
Enterprise Value 7.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.42
Price/Book (mrq)3.28
Enterprise Value/Revenue 32.57
Enterprise Value/EBITDA -7.77

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 366.67%
S&P500 52-Week Change 322.36%
52 Week High 30.0400
52 Week Low 30.0036
50-Day Moving Average 30.0154
200-Day Moving Average 30.0093

Share Statistics

Avg Vol (3 month) 310.71k
Avg Vol (10 day) 310.56k
Shares Outstanding 5411.55M
Implied Shares Outstanding 61B
Float 8363.77M
% Held by Insiders 111.61%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Apr 30, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-103.54%

Management Effectiveness

Return on Assets (ttm)-15.90%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)222.04k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -825.5k
Net Income Avi to Common (ttm)-1.1M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)349.28k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.03M
Total Debt/Equity (mrq)197.01%
Current Ratio (mrq)0.18
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)115.4k
Levered Free Cash Flow (ttm)314.6k